Clinical features of hepatitis D

Seminars in Liver Disease

Volumn 32, Issue 3, 2012, Pages 228-236

  Farci, Patrizia ^a   Niro, Graziaanna ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

acute hepatitis D; chronic hepatitis D; cirrhosis; clinical features; hepatitis D virus; hepatocellular carcinoma; liver pathology; viral interaction

Indexed keywords

ACUTE HEPATITIS; ARTICLE; CHRONIC HEPATITIS; CLINICAL FEATURE; DELTA AGENT HEPATITIS; DISEASE COURSE; DISEASE SEVERITY; GENOTYPE; HEPATITIS DELTA VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LIVER FIBROSIS; MIXED INFECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SUPERINFECTION;

CARCINOMA, HEPATOCELLULAR; COINFECTION; GENOTYPE; HEPATITIS B; HEPATITIS C; HEPATITIS D; HEPATITIS D, CHRONIC; HEPATITIS DELTA VIRUS; HIV INFECTIONS; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; SUPERINFECTION;

EID: 84865466228     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0032-1323628     Document Type: Article

References (80)

1. Rizzetto M, Canese MG, Aricò S., et al. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut: 1977; 18 12 997 1003
2. Rizzetto M, Canese MG, Gerin JL, London WT, Sly DL, Purcell RH. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis: 1980; 141 5 590 602
3. Rizzetto M, Smedile A. Hepatitis D. In: Schiff ER, Sorrell M, Maddrey W., eds. Diseases of the Liver. Philadelphia, PA Lippincott, Williams and Wilkins: 2002; 863 875
4. Farci P. Delta hepatitis: an update. J Hepatol: 2003; 39 01 S212 S219
5. Taylor J, Farci P, Purcell RH. Hepatitis D (Delta) virus. In: Knipe DM, Howley PM., eds. Field's Virology. 5th ed. Philadelphia, PA Lippincott, Williams and Wilkins: 2006; 3031 3046
6. Purcell RH, Satterfield WC, Bergmann KF, Smedile A, Ponzetto A, Gerin JL. Experimental hepatitis delta virus infection in the chimpanzee. Prog Clin Biol Res: 1987; 234 27 36
7. Caredda F, Rossi E, d'Arminio Monforte A., et al. Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome. J Infect Dis: 1985; 151 5 925 928
8. Smedile A, Farci P, Verme G., et al. Influence of delta infection on severity of hepatitis B. Lancet: 1982; 2 8305 945 947
9. Smedile A, Ciancio A, Rizzetto M. Hepatitis D. In: Richmann DD, Whitley RJ, Hayden FG., eds. Clinical Virology: Hepatitis Delta Virus. Washington, DC ASM Press: 2002; 1227 1240
10. Raimondo G, Longo G, Squadrito G. Exacerbation of chronic liver disease due to hepatitis B surface antigen after delta infection. Br Med J (Clin Res Ed): 1983; 286 6368 845
11. Farci P, Smedile A, Lavarini C., et al. Delta hepatitis in inapparent carriers of hepatitis B surface antigen. A disease simulating acute hepatitis B progressive to chronicity. Gastroenterology: 1983; 85 3 669 673
12. Smedile A, Dentico P, Zanetti A., et al. Infection with the delta agent in chronic HBsAg carriers. Gastroenterology: 1981; 81 6 992 997
13. Niro GA, Gravinese E, Martini E., et al. Clearance of hepatitis B surface antigen in chronic carriers of hepatitis delta antibodies. Liver: 2001; 21 4 254 259
14. Ottobrelli A, Marzano A, Smedile A., et al. Patterns of hepatitis delta virus reinfection and disease in liver transplantation. Gastroenterology: 1991; 101 6 1649 1655
15. Smedile A, Casey JL, Cote PJ., et al. Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with a hepatitis B surface antigen envelope. Hepatology: 1998; 27 6 1723 1729
16. Lee WM. Acute liver failure. N Engl J Med: 1993; 329 25 1862 1872
17. Trey C. The fulminant hepatic failure surveillance study. Brief review of the effects of presumed etiology and age of survival. Can Med Assoc J: 1972; 106 525 528
18. Saracco G, Macagno S, Rosina F, Rizzetto M. Serologic markers with fulminant hepatitis in persons positive for hepatitis B surface antigen. A worldwide epidemiologic and clinical survey. Ann Intern Med: 1988; 108 3 380 383
19. Rizzetto M, Verme G, Recchia S., et al. Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med: 1983; 98 4 437 441
20. Saracco G, Rosina F, Brunetto MR., et al. Rapidly progressive HBsAg-positive hepatitis in Italy. The role of hepatitis delta virus infection. J Hepatol: 1987; 5 3 274 281
21. Fattovich G, Giustina G, Christensen E., et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). Gut: 2000; 46 3 420 426
22. Rosina F, Conoscitore P, Cuppone R., et al. Changing pattern of chronic hepatitis D in Southern Europe. Gastroenterology: 1999; 117 1 161 166
23. Verme G, Brunetto MR, Oliveri F., et al. Role of hepatitis delta virus infection in hepatocellular carcinoma. Dig Dis Sci: 1991; 36 8 1134 1136
24. Romeo R, Del Ninno E, Rumi M., et al. A 28-year study of the course of hepatitis delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology: 2009; 136 5 1629 1638
25. Niro GA, Smedile A, Ippolito AM., et al. Outcome of chronic delta hepatitis in Italy: a long-term cohort study. J Hepatol: 2010; 53 5 834 840
26. Cross TJ, Rizzi P, Horner M., et al. The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol: 2008; 80 2 277 282
27. Buti M, Homs M, Rodriguez-Frias F., et al. Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study. J Viral Hepat: 2011; 18 6 434 442
28. Sakugawa H, Nakasone H, Nakayoshi T., et al. Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection. J Med Virol: 2001; 65 3 478 484
29. Zachou K, Yurdaydin C, Drebber U., et al. HIDT-1 Study Group. Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis. Liver Int: 2010; 30 3 430 437
30. Farci P, Gerin JL, Aragona M., et al. Diagnostic and prognostic significance of the IgM antibody to the hepatitis delta virus. JAMA: 1986; 255 11 1443 1446
31. Borghesio E, Rosina F, Smedile A., et al. Serum immunoglobulin M antibody to hepatitis D as a surrogate marker of hepatitis D in interferon-treated patients and in patients who underwent liver transplantation. Hepatology: 1998; 27 3 873 876
32. Crivelli O, Lavarini C, Chiaberge E., et al. Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent. Clin Exp Immunol: 1983; 54 1 232 238
33. Philipp T, Durazzo M, Trautwein C., et al. Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D. Lancet: 1994; 344 8922 578 581
34. Lavarini C, Caredda F, Ballarè M., et al. Development of tissue antibodies in hepatitis delta virus infection. In: Zuckermann AJ., ed. Viral Hepatitis and Liver Disease. New York Liss: 1988; 439 441
35. Rosina F, Pintus C, Meschievitz C, Rizzetto M. A randomized controlled trial of a 12-month course of recombinant human interferon-alpha in chronic delta (type D) hepatitis: a multicenter Italian study. Hepatology: 1991; 13 6 1052 1056
36. Verme G, Amoroso P, Lettieri G., et al. A histological study of hepatitis delta virus liver disease. Hepatology: 1986; 6 6 1303 1307
37. Govindarajan S, de Cock KM, Peters RL. Morphologic and immunohistochemical features of fulminant delta hepatitis. Hum Pathol: 1985; 16 3 262 267
38. Popper H, Thung SN, Gerber MA., et al. Histologic studies of severe delta agent infection in Venezuelan Indians. Hepatology: 1983; 3 6 906 912
39. Deny P. Hepatitis delta virus genetic variability: from genotypes I, II, III to eight major clades. In: Casey JL., ed. Hepatitis Delta Virus. Heidelberg, Germany Springer: 2006; 151 171
40. Niro GA, Smedile A, Andriulli A, Rizzetto M, Gerin JL, Casey JL. The predominance of hepatitis delta virus genotype I among chronically infected Italian patients. Hepatology: 1997; 25 3 728 734
41. Wu JC. Functional and clinical significance of hepatitis D virus genotype II infection. Curr Top Microbiol Immunol: 2006; 307 173 186
42. Su CW, Huang YH, Huo TI., et al. Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients. Gastroenterology: 2006; 130 6 1625 1635
43. Casey JL, Brown TL, Colan EJ, Wignall FS, Gerin JL. A genotype of hepatitis D virus that occurs in northern South America. Proc Natl Acad Sci U S A: 1993; 90 19 9016 9020
44. Manock SR, Kelley PM, Hyams KC., et al. An outbreak of fulminant hepatitis delta in the Waorani, an indigenous people of the Amazon basin of Ecuador. Am J Trop Med Hyg: 2000; 63 3-4 209 213
45. Gomes-Gouvêa MS, Soares MC, Bensabath G., et al. Hepatitis B virus and hepatitis delta virus genotypes in outbreaks of fulminant hepatitis (Labrea black fever) in the western Brazilian Amazon region. J Gen Virol: 2009; 90 Pt 11 2638 2643
46. Radjef N, Gordien E, Ivaniushina V., et al. Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades. J Virol: 2004; 78 5 2537 2544
47. Gaeta GB, Stroffolini T, Chiaramonte M., et al. Chronic hepatitis D: a vanishing disease? An Italian multicenter study. Hepatology: 2000; 32 4 Pt 1 824 827
48. Rizzetto M. Hepatitis D: thirty years after. J Hepatol: 2009; 50 5 1043 1050
49. Wedemeyer H, Heidrich B, Manns MP. Hepatitis D virus infectionnot a vanishing disease in Europe! Hepatology: 2007; 45 5 1331 1332, author reply 1332-1333
50. Gaeta GB, Stroffolini T, Smedile A, Niro G, Mele A. Hepatitis delta in Europe: vanishing or refreshing? Hepatology: 2007; 46 4 1312 1313
51. Erhardt A, Knuth R, Sagir A, Kirschberg O, Heintges T, Häussinger D. Socioepidemiological data on hepatitis delta in a German university clinicincrease in patients from Eastern Europe and the former Soviet Union. Z Gastroenterol: 2003; 41 6 523 526
52. Yurdaydin C. Delta hepatitis in Turkey: decreasing but not vanishing and still of concern. Turk J Gastroenterol: 2006; 17 1 74 75
53. Crockett SD, Keeffe EB. Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection. Ann Clin Microbiol Antimicrob: 2005; 4 13
54. Ganesh Kumar A, Sridharan K, Thirunalasundari T. Prevalence pattern of blood borne hepatitis group of viruses in liver disease patients. World Med Sci: 2007; 2 33 38
55. Bertoletti A, Ferrari C. Kinetics of the immune response during HBV and HCV infection. Hepatology: 2003; 38 1 4 13
56. Riaz M, Idrees M, Kanwal H, Kabir F. An overview of triple infection with hepatitis B, C and D viruses. Virol J: 2011; 8 368
57. Liaw Y-F, Tsai S-L, Sheen I-S., et al. Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers. Am J Gastroenterol: 1998; 93 3 354 359
58. Wu JC, Chen CL, Hou MC, Chen TZ, Lee SD, Lo KJ. Multiple viral infection as the most common cause of fulminant and subfulminant viral hepatitis in an area endemic for hepatitis B: application and limitations of the polymerase chain reaction. Hepatology: 1994; 19 4 836 840
59. Sagnelli E, Coppola N, Scolastico C., et al. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis. Hepatology: 2000; 32 5 1106 1110
60. Mathurin P, Thibault V, Kadidja K., et al. Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections. J Viral Hepat: 2000; 7 1 15 22
61. Jardi R, Rodriguez F, Buti M., et al. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology: 2001; 34 2 404 410
62. Raimondo G, Brunetto MR, Pontisso P., et al. Associazione Italiana Studio Fegato Cooperative Group. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients. Hepatology: 2006; 43 1 100 107
63. Colombari R, Dhillon AP, Piazzola E., et al. Chronic hepatitis in multiple virus infection: histopathological evaluation. Histopathology: 1993; 22 4 319 325
64. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology: 2004; 127 5, Suppl 1 S35 S50
65. Oyunsuren T, Kurbanov F, Tanaka Y., et al. High frequency of hepatocellular carcinoma in Mongolia; association with mono-, or co-infection with hepatitis C, B, and delta viruses. J Med Virol: 2006; 78 12 1688 1695
66. Tsatsralt-Od B, Takahashi M, Nishizawa T, Endo K, Inoue J, Okamoto H. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia. J Med Virol: 2005; 77 4 491 499
67. Khan A, Kurbanov F, Tanaka Y., et al. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan. J Med Virol: 2008; 80 2 268 276
68. Pontisso P, Ruvoletto MG, Fattovich G., et al. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology: 1993; 105 5 1529 1533
69. Modahl LE, Lai MM. The large delta antigen of hepatitis delta virus potently inhibits genomic but not antigenomic RNA synthesis: a mechanism enabling initiation of viral replication. J Virol: 2000; 74 16 7375 7380
70. Deterding K, Pothakamuri SV, Schlaphoff V., et al. Clearance of chronic HCV infection during acute delta hepatitis. Infection: 2009; 37 2 159 162
71. Benhamou Y, Bochet M, Di Martino V., et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology: 1999; 30 1054 1058
72. Puoti M, Bonacini M, Spinetti A., et al. Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus. J Infect Dis: 2001; 183 134 137
73. Gaeta GB, Precone DF, Cozzi-Lepri A, Cicconi P, D'Arminio Monforte A. Multiple viral infections. J Hepatol: 2006; 44 1, Suppl S108 S113
74. Arribas JR, González-García JJ, Lorenzo A., et al. Single (B or C), dual (BC or BD) and triple (BCD) viral hepatitis in HIV-infected patients in Madrid, Spain. AIDS: 2005; 19 13 1361 1365
75. Boyd A, Lacombe K, Miailhes P., et al. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus. J Viral Hepat: 2010; 17 1 65 76
76. Pol S, Wesenfelder L, Dubois F., et al. Influence of human immunodeficiency virus infection on hepatitis delta virus superinfection in chronic HBsAg carriers. J Viral Hepat: 1994; 1 2 131 137
77. Schaper M, Rodriguez-Frias F, Jardi R., et al. Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D. J Hepatol: 2010; 52 5 658 664
78. Soriano V, Grint D, d'Arminio Monforte A., et al. Hepatitis delta in HIV-infected individuals in Europe. AIDS: 2011; 25 16 1987 1992
79. Castellares C, Barreiro P, Martín-Carbonero L., et al. Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome. J Viral Hepat: 2008; 15 3 165 172
80. Rizzetto M. Delta hepatitis: Forgotten, but not gone. Curr Hepatitis Rep: 2010; 9 239 242